Neuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells
- PMID: 21705974
- PMCID: PMC6264347
- DOI: 10.3390/molecules16075349
Neuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells
Abstract
Gastrodia elata Blume (GE) has long been used in oriental countries as a traditional herbal medicine to relieve symptoms associated with neurological ailments such as vertigo, general paralysis and epilepsy. In this study, we have investigated the effects of GE extracts and its major bioactive components on 1-methyl-4-phenylpyridinium (MPP+)-treated MN9D dopaminergic cells, a classic in vitro model for Parkinson's disease (PD). We found that vanillyl alcohol effectively inhibited the cytotoxicity and improved cell viability in MPP+-induced MN9D dopaminergic cells. The underlying mechanisms of vanillyl alcohol action were also studied. Vanillyl alcohol attenuated the elevation of reactive oxygen species (ROS) levels, decreased in the Bax/Bcl-2 ratio and poly (ADP-ribose) polymerase proteolysis. These results indicate that vanillyl alcohol protected dopaminergic MN9D cells against MPP+-induced apoptosis by relieving oxidative stress and modulating the apoptotic process and is therefore a potential candidate for treatment of neurodegenerative diseases such as Parkinson's disease.
Figures
Similar articles
-
Protective effects of Gastrodia elata Blume on MPP+-induced cytotoxicity in human dopaminergic SH-SY5Y cells.J Ethnopharmacol. 2010 Jul 20;130(2):290-8. doi: 10.1016/j.jep.2010.05.006. Epub 2010 May 12. J Ethnopharmacol. 2010. PMID: 20470875
-
Gastrodin protects against MPP(+)-induced oxidative stress by up regulates heme oxygenase-1 expression through p38 MAPK/Nrf2 pathway in human dopaminergic cells.Neurochem Int. 2014 Sep;75:79-88. doi: 10.1016/j.neuint.2014.06.003. Epub 2014 Jun 14. Neurochem Int. 2014. PMID: 24932697
-
Glial Nrf2 signaling mediates the neuroprotection exerted by Gastrodia elata Blume in Lrrk2-G2019S Parkinson's disease.Elife. 2021 Nov 15;10:e73753. doi: 10.7554/eLife.73753. Elife. 2021. PMID: 34779396 Free PMC article.
-
The rhizome of Gastrodia elata Blume - An ethnopharmacological review.J Ethnopharmacol. 2016 Aug 2;189:361-85. doi: 10.1016/j.jep.2016.06.057. Epub 2016 Jul 1. J Ethnopharmacol. 2016. PMID: 27377337 Review.
-
Gastrodia elata and epilepsy: Rationale and therapeutic potential.Phytomedicine. 2016 Nov 15;23(12):1511-1526. doi: 10.1016/j.phymed.2016.09.001. Epub 2016 Sep 5. Phytomedicine. 2016. PMID: 27765372 Review.
Cited by
-
Medicinal herbal remedies in neurodegenerative diseases: an update on antioxidant potential.Naunyn Schmiedebergs Arch Pharmacol. 2024 Mar 13. doi: 10.1007/s00210-024-03027-5. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38472370 Review.
-
The neuroprotective effect of traditional Chinese medicinal plants-A critical review.Acta Pharm Sin B. 2023 Aug;13(8):3208-3237. doi: 10.1016/j.apsb.2023.06.009. Epub 2023 Jun 20. Acta Pharm Sin B. 2023. PMID: 37655317 Free PMC article. Review.
-
Bioactivity Profiling and Quantification of Gastrodin in Gastrodia elata Cultivated in the Field versus Facility via Hyphenated High-Performance Thin-Layer Chromatography.Int J Mol Sci. 2023 Jun 9;24(12):9936. doi: 10.3390/ijms24129936. Int J Mol Sci. 2023. PMID: 37373083 Free PMC article.
-
The effects of bioactive components from the rhizome of gastrodia elata blume (Tianma) on the characteristics of Parkinson's disease.Front Pharmacol. 2022 Nov 30;13:963327. doi: 10.3389/fphar.2022.963327. eCollection 2022. Front Pharmacol. 2022. PMID: 36532787 Free PMC article. Review.
-
Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in Schizophrenia.Antioxidants (Basel). 2022 Nov 17;11(11):2275. doi: 10.3390/antiox11112275. Antioxidants (Basel). 2022. PMID: 36421461 Free PMC article. Review.
References
-
- Dorsey E.R., Constantinescu R., Thompson J.P., Biglan K.M., Holloway R.G., Kieburtz K., Marshall F.J., Ravina B.M., Schifitto G., Siderowf A., et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68:384–386. doi: 10.1212/01.wnl.0000247740.47667.03. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
